Outcomes for Lymph Node-Positive Cutaneous Melanoma Over Two Decades
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://www.springerlink.com/index/pdf/10.1007/s00268-010-0903-8
Reference29 articles.
1. Balch CM, Soong SJ, Atkins MB et al (2004) An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:131–149
2. Bottomley A, Coens C, Suciu S et al (2009) Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol 27:2916–2923
3. Eggermont AM, Suciu S, Santinami M et al (2008) Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet 372(9633):117–126
4. Kirkwood JM, Ibrahim JG, Sosman JA et al (2001) High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 19:2370–2380
5. Kirkwood JM, Manola J, Ibrahim J et al (2004) A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res 10:1670–1677
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review;Melanoma Management;2020-05
2. Gender Differences and Outcomes in Melanoma Patients;Oncology and Therapy;2020-02-04
3. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma;Medical Science Monitor;2019-05-18
4. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non–Small-Cell Lung Cancer: A Competing Risk Analysis;Clinical Lung Cancer;2018-03
5. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis;BMC Cancer;2016-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3